DENVER, Colo., Nov 9, 2023 (www.247marketnews.com)- We covered Senti Biosciences Inc. (NASDAQ: SNTI) on Tuesday, following its new strategic collaboration with Celest Therapeutics news, when it was trading at $0.5903.
Senti Biosciences is now trading at $0.77, up $0.09 (+13.24%) on 1.64Mshares.
Its 52-week range is $0.2701 to $2.75.
On Tuesday we stated “It set a new 52-week low late October, but has bounced well off of that level. It attempted to fight through significant resistance around the 70-cent level for much of the premarket and, if it can break through that, on strong volume, it could take a shot at the dollar range.”
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.
The stocks and strategies discussed are simply ideas only and are in no way financial advice or recommendations. The author may or may not at any time be holding securities discussed. The author may or may not enter trades in the stocks mentioned. Some positions in mentioned stocks may already be held or are being adjusted or are simply examples, ideas or discussion topics. You are always trading at your own risk.